BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34800547)

  • 1. Genomic instability, inflammatory signaling and response to cancer immunotherapy.
    Chen M; Linstra R; van Vugt MATM
    Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188661. PubMed ID: 34800547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory signaling in genomically instable cancers.
    Talens F; Van Vugt MATM
    Cell Cycle; 2019 Aug; 18(16):1830-1848. PubMed ID: 31260383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Instability in Cancer: Molecular Mechanisms and Therapeutic Potentials.
    Salmaninejad A; Ilkhani K; Marzban H; Navashenaq JG; Rahimirad S; Radnia F; Yousefi M; Bahmanpour Z; Azhdari S; Sahebkar A
    Curr Pharm Des; 2021; 27(28):3161-3169. PubMed ID: 33902409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA repair defects and implications for immunotherapy.
    Bever KM; Le DT
    J Clin Invest; 2018 Oct; 128(10):4236-4242. PubMed ID: 30272580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.
    Ye Z; Shi Y; Lees-Miller SP; Tainer JA
    Front Immunol; 2021; 12():797880. PubMed ID: 34970273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy.
    Huang JL; Chang YT; Hong ZY; Lin CS
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premature mitotic entry induced by ATR inhibition potentiates olaparib inhibition-mediated genomic instability, inflammatory signaling, and cytotoxicity in BRCA2-deficient cancer cells.
    Schoonen PM; Kok YP; Wierenga E; Bakker B; Foijer F; Spierings DCJ; van Vugt MATM
    Mol Oncol; 2019 Nov; 13(11):2422-2440. PubMed ID: 31529615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA Damage and Cancer Immunotherapy: A STING in the Tale.
    Reisländer T; Groelly FJ; Tarsounas M
    Mol Cell; 2020 Oct; 80(1):21-28. PubMed ID: 32810436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer.
    Chen M; Yu S; van der Sluis T; Zwager MC; Schröder CP; van der Vegt B; van Vugt MATM
    NPJ Breast Cancer; 2024 Jan; 10(1):1. PubMed ID: 38167507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance.
    Carloni V; Morganti E; Galli A; Mazzocca A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between the DNA Damage Response and Immunotherapy Response in Cancer.
    Lee ECY; Kok JST; Teh BT; Lim KS
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
    Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils and micronuclei: An emerging link between genomic instability and cancer-driven inflammation.
    Bui TM; Sumagin R
    Mutat Res; 2022; 824():111778. PubMed ID: 35334355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Genomic Instability in Breast Cancer.
    Duijf PHG; Nanayakkara D; Nones K; Srihari S; Kalimutho M; Khanna KK
    Trends Mol Med; 2019 Jul; 25(7):595-611. PubMed ID: 31078431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear Envelope Integrity in Health and Disease: Consequences on Genome Instability and Inflammation.
    Gauthier BR; Comaills V
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA damage induced immune response: Implications for cancer therapy.
    Barros EM; McIntosh SA; Savage KI
    DNA Repair (Amst); 2022 Dec; 120():103409. PubMed ID: 36308822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When breaks get hot: inflammatory signaling in BRCA1/2-mutant cancers.
    van Vugt MATM; Parkes EE
    Trends Cancer; 2022 Mar; 8(3):174-189. PubMed ID: 35000881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase (PTP) inhibition enhances chromosomal stability after genotoxic stress: decreased chromosomal instability (CIN) at the expense of enhanced genomic instability (GIN)?
    Kost GC; Patierno SR; Wise SS; Holmes AL; Wise JP; Ceryak S
    Mutat Res; 2012 Jul; 735(1-2):51-5. PubMed ID: 22583656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment.
    Caracciolo D; Riillo C; Arbitrio M; Di Martino MT; Tagliaferri P; Tassone P
    Int J Cancer; 2020 Nov; 147(10):2658-2668. PubMed ID: 32383203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cGAS Paradox: Contrasting Roles for cGAS-STING Pathway in Chromosomal Instability.
    Hong C; Tijhuis AE; Foijer F
    Cells; 2019 Oct; 8(10):. PubMed ID: 31658669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.